interesting.
like this bit
"has to be careful about how they publicise the new TAVR device.
It’s a single tissue valve that is installed in the aortic artery via the leg, rather than via open heart surgery, and is competing with other products that involve more pieces of tissue and therefore more stitches.
Admedus wants to sign two of the big four global device makers to co-develop it this year.
But Mr Paterson says he can’t reveal whether it’s Medtronic, Edwards Lifescience, St Jude Medical or Boston Scientific in case they decide it’s simpler to buy the $60 million company while it’s cheap."
Admedus head and neck cancer trial, page-69
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.68 |
Change
0.680(4.53%) |
Mkt cap ! $331.4M | |||
| Open | High | Low | Value | Volume |
| $14.90 | $15.75 | $14.85 | $431.9K | 28.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.95 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |